Skip to Content

MAXALT 5MG TABLETS

Active substance(s): RIZATRIPTAN / RIZATRIPTAN BENZOATE

View full screen / Print PDF » Download PDF ⇩
Transcript
Assessed against UK PIL dated October 2013

MOCK-UP

PACKAGE LEAFLET: INFORMATION FOR THE USER
MAXALT® 5mg TABLETS / RIZATRIPTAN 5mg TABLETS
(rizatriptan benzoate)
This product is available using any of the above names but will be referred to as Maxalt throughout the following
leaflet. Please note that the leaflet also contains information about other strengths (Maxalt 10mg Tablets).
Read all of this leaflet carefully before you start taking this medicine

Keep this leaflet. You may need to read it again.

If you have further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their
symptoms are the same as yours.

If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your
doctor or pharmacist.

By rajeevkumarj at

In this leaflet:
1. What Maxalt is and what it is used for
2. Before you take Maxalt
3. How to take Maxalt
4. Possible side effects
5. How to store Maxalt
6. Further information
1. WHAT MAXALT IS AND WHAT IT IS USED FOR
Maxalt belongs to a class of medicines called selective serotonin 5-HT1B/1D receptor agonists.
Maxalt is used to treat the headache phase of the migraine attack in adults.
Treatment with Maxalt:
Reduces swelling of blood vessels surrounding the brain. This swelling results in the headache pain of a migraine attack.
2. BEFORE YOU TAKE MAXALT
Do not take Maxalt if:
• you are allergic (hypersensitive) to rizatriptan benzoate or any of the other ingredients of Maxalt
• you have moderately severe or severe high blood pressure or mild high blood pressure that is not controlled by
medication
• you have or have ever had heart problems including heart attack or pain on the chest (angina) or you have
experienced heart disease related signs
• you have severe liver or severe kidney problems
• you have had a stroke (cerebrovascular accident CVA) or mini stroke (transient ischaemic attack TIA)
• you have blockage problems with your arteries (peripheral vascular disease)
• you are taking monoamine oxidase (MAO) inhibitors such as moclobemide, phenelzine, tranylcypromine, or
pargyline (drugs against depression), or linezolid (an antibiotic), or if it has been less than two weeks since you
stopped taking MAO inhibitors
• you are now taking ergotamine-type medications, such as ergotamine or dihydro-ergotamine to treat your
migraine or methysergide to prevent a migraine attack
• you are taking any other drug in the same class, such as sumatriptan, naratriptan, or zolmitriptan to treat your
migraine (see Taking with other medicines below).
If you are not sure if any of the above apply to you talk to your doctor or pharmacist before taking Maxalt.
Take special care with Maxalt if you:
Before you take Maxalt, tell your doctor or pharmacist, if:
• you have any of the following risk factors for heart disease: high blood pressure, diabetes, you smoke or you
are using nicotine substitution, your family has a history of heart disease, you are a man over 40 years of age,
or you are a post-menopausal woman
• you have kidney or liver problems
• you have a particular problem with the way your heart beats (bundle branch block)
• you have or have had any allergies
• your headache is associated with dizziness, difficulty in walking, lack of co-ordination or weakness in the leg and arm
• you use herbal preparation containing St. John’s wort
• you have had allergic reaction like swelling of face, lips, tongue and/or throat which may cause difficulty
breathing and/or swallowing (angioedema)
• you are taking selective serotonin reuptake inhibitors (SSRIs) such as sertraline, escitalopram oxalate, and fluoxetine
or serotonin norepinephrine reuptake inhibitors (SNRIs) such as venlafaxine, and duloxetine for depression
• you have had short lived symptoms including chest pain and tightness.
If you take Maxalt too often this may result in you getting a chronic headache. In such cases you should contact
your doctor as you may have to stop taking Maxalt.
Please tell your doctor or pharmacist about your symptoms. Your doctor will decide if you have migraine. You
should take Maxalt only for a migraine attack. Maxalt should not be used to treat headaches that might be caused
by other, more serious conditions.
Please tell your doctor if you are taking or have recently taken, or plan to take, any other medicines including medicines
obtained without a prescription. This includes herbal medicines and those you normally take for a migraine. This is
because Maxalt can affect the way some medicines work. Also, other medicines can affect Maxalt.
Taking with other medicines
Do not take Maxalt
• if you are already taking a 5-HT1B/1D agonist (sometimes referred to as ‘triptans’), such as sumatriptan,
naratriptan or zolmitriptan.
• if you are taking a monoamine oxidase (MAO) inhibitor such as moclobemide, phenelzine, tranylcypromine,
linezolid, or pargyline or if it has been less than two weeks since you stopped taking an MAO inhibitor.
• if you use ergotamine-type medications such as ergotamine or dihydro-ergotamine to treat your migraine.
• if you use methysergide to prevent a migraine attack.
The above listed medicines when taken with Maxalt may increase the risk of side effects.
You should wait at least 6 hours after taking Maxalt before you take ergotamine-type medications such as
ergotamine or dihydro-ergotamine or methysergide.
You should wait at least 24 hours after taking ergotamine-type medications before taking Maxalt.
Ask your doctor for instructions and the risks about taking Maxalt
• if you are taking propranolol (see section 3: HOW TO TAKE MAXALT).
• if you are taking SSRIs such as sertraline, escitalopram oxalate, and fluoxetine or SNRIs such as venlafaxine,
and duloxetine for depression.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including
medicines obtained without a prescription.
Taking Maxalt with food and drink
Maxalt can take longer to work if it is taken after food. Although it is better to take it on an empty stomach, you can
still take it if you have eaten.
Pregnancy and breast-feeding
It is not known whether Maxalt is harmful to an unborn baby when taken by a pregnant woman.
Talk to your doctor before taking this medicine if you are pregnant, planning to get pregnant or are breastfeeding.
Breastfeeding should be avoided for 24 hours after treatment.
Ask your doctor or pharmacist for advice before taking any medicine.
Use in children
The use of Maxalt tablets in children under 18 years of age is not recommended.
Use in patients older than 65 years
There have been no full studies to look at how safe and effective Maxalt is amongst patients older than 65 years.
Driving or using machines
You may feel sleepy or dizzy while taking Maxalt. If this happens, do not drive or use any tools or machines.
Important information about some of the ingredients of Maxalt
The 5-mg tablet contains 30.25 mg of lactose monohydrate and the 10-mg tablet contains 60.50 mg of lactose
monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your
doctor before taking this medicinal product.
3. HOW TO TAKE MAXALT
Maxalt is used to treat migraine attacks. Take Maxalt as soon as possible after your migraine headache has
started. Do not use it to prevent an attack.
Always take Maxalt exactly as your doctor has told you. You should check with your doctor or your pharmacist if
you are not sure.
The usual dose is 10 mg.
If you are currently taking propranolol or have kidney or liver problems you should use the 5-mg dose of Maxalt. You
should leave at least 2 hours between taking propranolol and Maxalt up to a maximum of 2 doses in a 24-hour period.

Maxalt (rizatriptan benzoate) tablets should be taken by mouth and swallowed whole with liquid.
Maxalt is also available as a 10-mg oral lyophilisate that dissolves in the mouth. The oral lyophilisate can be used
in situations in which liquids are not available, or to avoid the nausea and vomiting that may accompany the
ingestion of tablets with liquids.
If migraine returns within 24 hours
In some patients, migraine symptoms can return within a 24-hour period. If your migraine does return you can take
an additional dose of Maxalt. You should always wait at least 2 hours between doses.
If after 2 hours you still have a migraine
If you do not respond to the first dose of Maxalt during an attack, you should not take a second dose of Maxalt for
treatment of the same attack. It is still likely, however, that you will respond to Maxalt during the next attack.
Do not take more than 2 doses of Maxalt in a 24-hour period, (for example, do not take more than two 10 mg or 5
mg tablets or oral lyophilisate in a 24-hour period). You should always wait at least 2 hours between doses.
If your condition worsens, seek medical attention.
If you take more Maxalt than you should:
If you take more Maxalt than you should, talk to your doctor or pharmacist straight away. Take the medicine pack with you.
Signs of overdosage can include dizziness, drowsiness, vomiting, fainting and slow heart rate.
If you have any further questions on the use of this product ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, Maxalt can cause side effects, although not everybody gets them. The following side effects
may happen with this medicine.
In adult studies, the most common side effects reported were dizziness, sleepiness and tiredness.
Common (affects 1 to 10 users in 100)
• tingling (paraesthesia), headache, decreased sensitivity of skin (hypoaesthesia), decreased mental sharpness, tremor,
• fast or irregular heart beat (palpitation), very fast heartbeat (tachycardia),
• flushing (redness of the face lasting a short time), hot flushes, sweating,
• throat discomfort, difficulty breathing (dyspnoea),
• feeling sick (nausea), dry mouth, vomiting, diarrhoea,
• feeling of heaviness in parts of the body,
• pain in abdomen or chest.
Uncommon (affects 1 to 10 users in 1000)
• bad taste in your mouth.
• unsteadiness when walking (ataxia), dizziness (vertigo), blurred vision.
• confusion, insomnia, nervousness.
• high blood pressure (hypertension); thirst, indigestion (dyspepsia).
• rash, itching and lumpy rash (hives); swelling of face, lips, tongue and/or throat which may cause difficulty
breathing and/or swallowing (angioedema).
• neck pain, feeling of tightness in parts of the body, stiffness, muscle weakness.
• changes in the rhythm or rate of the heartbeat (arrhythmia); abnormalities of the electrocardiogram (a test that
records the electrical activity of your heart).
• facial pain; muscle pain.
Rare (affects 1 to 10 users in 10,000)
• fainting (syncope).
• wheezing.
• allergic reaction (hypersensitivity); sudden life-threatening allergic reaction (anaphylaxis).
• stroke (this generally occurs in patients with risk factors for heart and blood vessel disease (high blood
pressure, diabetes, smoking, use of nicotine substitution, family history of heart disease or stroke, man over 40
years of age, post-menopausal women, particular problem with the way your heart beats [bundle branch block]).
• slow heartbeat (bradycardia).
Not known (frequency cannot be estimated from the available data):
• heart attack, spasm of the blood vessels of the heart (these generally occur in patients with risk factors for heart
and blood vessel disease (high blood pressure, diabetes, smoking, use of nicotine substitution, family history of
heart disease or stroke, man over 40 years of age, postmenopausal women, particular problem with the way
your heart beats (bundle branch block)).
• a syndrome called “serotonin syndrome” that may cause side effects like coma, unstable blood pressure,
extremely high body temperature, lack of muscle coordination, agitation and hallucinations.
• severe shedding of the skin with or without fever (toxic epidermal necrolysis).
• seizure (convulsions/fits).
• spasm of blood vessels of the extremities including coldness and numbness of the hands or feet.
• spasm of the blood vessels of the colon (large bowel), which can cause abdominal pain.
Tell your doctor right away if you have symptoms of allergic reactions, serotonin syndrome, heart attack or
stroke.
In addition, tell your doctor if you experience any symptoms that suggest an allergic reaction (such as a rash or
itching) after taking Maxalt.
If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor
or pharmacist.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not
listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at:
www.mhra.gov.uk/yellowcard
By reporting side effects, you can help provide more information on the safety of this medicine.
5. HOW TO STORE MAXALT
• Keep Maxalt out of the sight and reach of children.
• Do not store Maxalt above 30°C.
• Do not use after the expiry date printed on the carton or blister labels.
• If your tablets become discoloured or show any other signs of deterioration, consult your pharmacist who will tell
you what to do.
• Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose
medicines no longer required. These measures will help to protect the environment.
6. FURTHER INFORMATION
Active ingredient: The active ingredient in Maxalt is rizatriptan (present as rizatriptan benzoate).
The tablets are pale pink, capsule-shaped tablets marked ‘MSD’ on one side and ‘266’ on the other.
Each 5 mg tablet contains 7.265 mg rizatriptan benzoate equivalent to 5 mg rizatriptan.
Other ingredients: lactose monohydrate, microcrystalline cellulose, pregelatinised maize starch, iron oxide (E172)
and magnesium stearate.
Pack sizes: 3 or 6 tablets per pack.
PL No: 15814/0308

Maxalt 5mg Tablets / Rizatriptan 5mg Tablets

POM

This product is manufactured by Merck Sharp & Dohme Limited, Shotton Lane, Cramlington, Northumberland
NE23 9JU, UK and is procured from within the EU and repackaged by the product licence holder: O.P.D.
Laboratories Ltd, Unit 6 Colonial Way, Watford, Herts. WD24 4PR.
Leaflet revision and issue date (Ref.): 18.11.2013.
Maxalt is a registered Trade Mark of Merck Sharp & Dohme Corp., Inc., New Jersey, U.S.A.
How can you obtain more information about Maxalt?
This leaflet gives you some of the most important information about Maxalt. If you have any questions after you
have read it, ask your doctor or pharmacist who can give you further information.
Further information about migraine is available from the following organisations:
Migraine Action Association
th
4 Floor, 27 East Street, Leicester, LE1 6NB. Tel: 0116 275 8317, Fax: 0116 254 2023.
and
The Migraine Trust
52-53 Russell Square, London, WC1B 4HP. Tel: 020 7631 6970, Fax: 020 7436 2886.
Email: info@migrainetrust.org
(Migraine Action Association and The Migraine Trust are independent organisations and are not associated with
Merck Sharp & Dohme Limited or OPD Laboratories Limited.)
To request a copy of this leaflet in Braille, large print or audio please call 01923 332 796.

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide